Fig. 3
From: LINC00311 is overexpressed in ankylosing spondylitis and predict treatment outcomes and recurrence
LINC00311 levels in plasma decreased after treatment. Plasma levels of LINC00311 were compared by performing paired t test between 2 time points. It was observed that, comparing to pre-treatment levels, plasma levels of LINC00311 were significantly reduced at 2 months after the initiation of treatment (*, p < 0.05)